Quarterly Sales and Earnings Data - Unaudited

12 Months Ended

Jan. 01, 2016

Quarterly Financial Information Disclosure [Abstract]

QUARTERLY SALES AND EARNINGS DATA - UNAUDITED

20. QUARTERLY SALES AND EARNINGS DATA—UNAUDITED

	4th Qtr.			3rd Qtr.		2nd Qtr.		1st Qtr.
	(in thousands, except per share data)
2015
Sales	$	317,567		$	146,637	$	174,890	$	161,320
Gross profit	73,140			51,646		57,951		52,398
Net income (loss)	(24,907		)	22		9,283		8,008
EPS—basic	(0.85		)	—		0.36		0.32
EPS—diluted	(0.85		)	—		0.35		0.31
2014
Sales	$	169,726		$	171,699	$	172,081	$	174,281
Gross profit	57,214			58,118		58,470		57,596
Net income	14,176			14,012		12,348		14,922
EPS—basic	0.57			0.56		0.50		0.61
EPS—diluted	0.54			0.54		0.48		0.58

Net income (loss) in the third and fourth quarters of 2015 include $13.0 million and $57.1 million, respectively, of charges incurred in connection with the Lake Region Medical acquisition (transaction and integration, inventory step-up amortization, debt related charges) and Spin-off of Nuvectra (professional and consulting fees). Sales for the fourth quarter of 2015 include $138.6 million from the acquisition of Lake Region Medical. Refer to Note 2 “Acquisitions.”